Literature DB >> 26226240

Can Grief be a Mental Disorder?: An Exploration of Public Opinion.

Lauren J Breen1, Emma L Penman, Holly G Prigerson, Lauren Y Hewitt.   

Abstract

Despite growing empirical evidence, the distinction between normal and pathological grief remains controversial. Few studies have investigated public attitudes towards distinguishing normal from pathological grief. An international sample of 348 participants from a wide range of cultures was asked if certain expressions of grief could be considered a mental disorder and to explain their answer. Analysis revealed that the majority (74.7%) agreed that grief could be considered a mental disorder. The presence of pervasive distress, of harm to self and/or others, functional impairment, and persistent grief were described as the circumstances under which grief can be a mental disorder. Reasons grief is not a mental disorder were that it is normal, temporary, in response to an event, and that efforts to include it in diagnostic manuals will lead to medicalization and stigma. The investigation of public norms informs the inclusion of pathological grief in diagnostic nosology.

Entities:  

Mesh:

Year:  2015        PMID: 26226240     DOI: 10.1097/NMD.0000000000000331

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  Evidence of the clinical utility of a prolonged grief disorder diagnosis.

Authors:  Wendy G Lichtenthal; Paul K Maciejewski; Caraline Craig Demirjian; Kailey E Roberts; Michael B First; David W Kissane; Robert A Neimeyer; William Breitbart; Elizabeth Slivjak; Greta Jankauskaite; Stephanie Napolitano; Andreas Maercker; Holly G Prigerson
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

2.  Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale.

Authors:  Holly G Prigerson; Paul A Boelen; Jiehui Xu; Kirsten V Smith; Paul K Maciejewski
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 79.683

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.